HIGH-RISK NEUROBLASTOMA

Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear

Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 2 Not yet finished but already full! 4 Completed 1

Promising drug duo targets childhood cancers that returned

Disease control Completed

This early-stage trial tested a combination of two lab-made antibodies, magrolimab and dinutuximab, in 12 children and young adults whose neuroblastoma or osteosarcoma had come back or stopped responding to treatment. The main goals were to find the safest dose and see if the dru…

Matched conditions: HIGH-RISK NEUROBLASTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 17, 2026 02:03 UTC

HIGH-RISK NEUROBLASTOMA

Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear

Promising drug duo targets childhood cancers that returned